Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilar adalimumab FKB-327 in the treatment of inflammatory bowel disease
Biosimilar adalimumab FKB-327 in the treatment of inflammatory bowel disease
2020
Milan Lukas
Martin Vašátko
Martin Lukas
Martin Kolář
Dana Duricova
N. Machkova
Karin Malickova
Veronika Hrubá
Keywords:
Gastroenterology
Biosimilar
Adalimumab
Inflammatory bowel disease
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]